Cetrotide cetrorelix: Completed Phase III enrollment

Aeterna completed enrollment of about 600 patients in a double-blind, placebo-controlled, international Phase III trial evaluating intramuscular Cetrotide given at weeks 0, 2, 26 and 28. In an open-la...